Payne, F. J. (2004). An evidence-based review of needle exchange programs. Washington: Children's AIDS Fund (CAF).
Keywords: harm reduction; HIV infection; Aids
|
Merki Frei, M. (2004). FiSu-FiDé : das leistungsbezogene Finanzierungssystem der Suchttherapie. Zürich: Trovacon.
Keywords: Aod; AOD dependence; AOD use, abuse, and dependence; health care costs; financial management; financing; managed care; Switzerland
|
Merki Frei, M. (2004). FiSu-FiDé : le système de financement des prestations pour les thérapies des dépendances. Zurich: Trovacon.
Keywords: Aod; AOD dependence; AOD use, abuse, and dependence; health care costs; financial management; financing; managed care; Switzerland
|
Merki Frei, M. (2004). FiSu-FiDé : il sistema di finanziamento delle terapie residenziali nel campo della dipendenza basato su prestationi. Zurigo: Trovacon.
Keywords: Aod; AOD dependence; AOD use, abuse, and dependence; health care costs; financial management; financing; managed care; Switzerland
|
Dietrich, N. (2003). La méthadone dans le modèle de la “thérapie résidentielle” : situation suisse. Berne: Centrale de coordination nationale de l'offre de thérapies résidentielles pour les problèmes de drogues (COSTE).
Keywords: treatment and maintenance; inpatient care
|
Niemann, S., Fahrni, S., Brügger, O., & Cavegn, M. (2008). Unfallgeschehen in der Schweiz : bfu-Statistik 2008. Bern: Beratungsstelle für Unfallverhütung (BFU).
Keywords: health promotion; statistical data; Switzerland
|
Niemann, S., Fahrni, S., Brügger, O., & Cavegn, M. (2008). Les accidents en Suisse : statistique 2008 du bpa. Berne: Bureau de prévention des accidents (BPA).
Keywords: health promotion; statistical data; Switzerland
|
Niemann, S., Fahrni, S., Brügger, O., & Cavegn, M. (2008). Gli incidenti in Svizzera : statistica upi 2008. Berna: Ufficio prevenzione infortuni (UPI).
Keywords: health promotion; statistical data; Switzerland
|
Somaini, B., Wang, J., Perozo, M., Kuhn, F., Meili, D., Grob, P., et al. (1999). A continuing concern : HIV and hepatitis testing and prevalence among drug users in substitution programs in Zurich, Switzerland. Zurich: Arbeitsgemeinschaft für risikoarmen Umgang mit Drogen (ARUD).
Abstract: Phase I of the Zurich Prometheus Study is a cross-sectional study focusing on an up-to-date serology for HIV and hepatitis B/C and associated risk factors for all clients in four participating clinics offering opiate substitution in Zurich, Switzerland. The mean age of the 603 respondents is 30.7 years (SD=6.2), and 38% of them are women. Seventy-five percent of the respondents have a history of injecting drug use (IDU), and over half have injected within the past six months. Lab-confirmed seroprevalence for HBV (50%) and HCV (57%) is twice that of HIV (24%). There is an 80% risk reduction for all three viral infections among those starting IDU after 1991—when harm reduction efforts were in full swing—compared to those who began before 1988—before clean needles were widely available. These findings suggest a strongly protective effective of harm reduction measures. But while a stabilization in HIV prevalence at 15% can be seen among drug users who started injecting after 1991, prevalence rates for HBV and HCV still remain several times higher. The prevalence data in this study support data showing continued high incidence rates for HBV and HCV, even among new injectors in the harm reduction era.
Keywords: health promotion; HIV infection; Aids
|
Andersson, B., Hibell, B., Beck, F., Choquet, M., Kokkevi, A., Fotiou, A., et al. (2007). Alcohol and drug use among european 17-18 year old students : data from the ESPAD project : full report. Stockholm: European School Survey Project on alcohol and Other Drugs (ESPAD); Swedish Council for Information on alcohol and Other Drugs (CAN); Council of Europe, Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (Pompidou Group).
Keywords: AOD use; alcohol; tobacco product; illicit drug; target group; adolescent; Europe
|